Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari
Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari
Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
Semaglutide Stocks: Aditya Khemka Warns of Pricing Collapse Despite Hype
Veteran health investor Aditya Khemka avoids semaglutide stocks due to lack of clarity on future market leaders and potential pricing collapse, despite growing demand for weight-loss drugs.
-
HPCL Shares: Motilal Oswal Maintains ‘Buy’ Rating, Sees 31% Upside – What Investors Should Know
Get the latest updates on HPCL shares, including Motilal Oswal’s ‘Buy’ rating and target price. Find out what’s driving the stock’s potential upside and how it may impact your investment portfolio.
-
Rupee Breaches 90 Level: Uday Kotak Weighs In On Foreign Selling
Billionaire Banker Uday Kotak comments on the Rupee breaching the 90 level against the US Dollar, citing foreign selling as the primary cause. Indian investors continue to buy, but will they be proven smarter in the long run?
-
HCC Stock Price Falls 4.93% Ahead of Record Date for Rs 1,000 Crore Rights Issue
HCC stock price drops 4.93% as the company prepares for a record date for its Rs 1,000 crore rights issue, aiming to raise funds without increasing debt burden.
-
Aequs IPO Sees Strong Demand on Day One: Should You Invest?
Aequs Ltd’s initial public offering (IPO) has opened for subscription with a strong response on day one. Here’s what you need to know before investing.
-
Meesho IPO: Anchor Book Allocation Sparks Controversy Amidst High Demand
Meesho’s highly anticipated IPO has garnered significant attention, with its anchor book allotment sparking controversy due to higher allocation to SBI Mutual Fund. Learn more about the IPO and its implications for Indian investors.